RASILEZ

This brand name is authorized in Austria, Canada, Cyprus, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Netherlands, Poland, Romania, United Kingdom, South Africa

Active ingredients

The drug RASILEZ contains one active pharmaceutical ingredient (API):

1 Aliskiren UNII C8A0P8G029 - ALISKIREN HEMIFUMARATE

Aliskiren is an orally active, non-peptide, potent and selective direct inhibitor of human renin. By inhibiting the enzyme renin, aliskiren inhibits the RAAS at the point of activation, blocking the conversion of angiotensinogen to angiotensin I and decreasing levels of angiotensin I and angiotensin II. Read about Aliskiren

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RASILEZ Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09XA02	Aliskiren	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09X Other agents acting on the renin-angiotensin system → C09XA Renin-inhibitors
Discover more medicines within C09XA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02302063, 02302071
Country: EE	Ravimiamet	Identifier(s): 1307023, 1307034, 1307045, 1307056, 1307067, 1307078, 1307089, 1307090, 1307102, 1307113, 1307124, 1307135, 1307146, 1307157, 1307168, 1307179, 1307180, 1307191, 1307203, 1307214
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 07405022, 07405032
Country: FR	Base de données publique des médicaments	Identifier(s): 61195604, 61280428
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 119610, 119618, 175904, 178849, 180663, 186092, 186094, 375325, 375328
Country: HK	Department of Health Drug Office	Identifier(s): 60309, 60310
Country: IE	Health Products Regulatory Authority	Identifier(s): 68210, 68211, 68250, 68255, 68280, 68281
Country: IT	Agenzia del Farmaco	Identifier(s): 038243010, 038243022, 038243034, 038243046, 038243059, 038243061, 038243073, 038243085, 038243097, 038243109, 038243111, 038243123, 038243135, 038243147, 038243150, 038243162, 038243174, 038243186, 038243198, 038243200, 038243212, 038243224, 038243236, 038243248, 038243251, 038243263, 038243275, 038243287, 038243299, 038243301, 038243313, 038243325, 038243337, 038243349, 038243352, 038243364, 038243376, 038243388, 038243390, 038243402
Country: JP	医薬品医療機器総合機構	Identifier(s): 2149047F1028
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1030623, 1030624, 1030625, 1030626, 1030627, 1030628, 1030629, 1030630, 1030631, 1030632, 1030633, 1030634, 1030635, 1030636, 1030637, 1030638, 1030639, 1030640, 1030641, 1030642, 1056696, 1056697, 1056698, 1056699, 1056700, 1056701, 1056702, 1056703, 1056704, 1056705, 1056706, 1056707, 1056708, 1056709, 1056710, 1056711, 1056712, 1056713, 1056714, 1056715
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 85065, 85073
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100147757, 100178657
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W52241001, W52241002, W52241003, W52241004, W52241005, W52241006, W52241007, W52241008, W52241009, W52241010, W52242001, W52242002, W52242003, W52242004, W52242005, W52242006, W52242007, W52242008, W52242009, W52242010
Country: ZA	Health Products Regulatory Authority	Identifier(s): 41/7.1.3/0971, 41/7.1.3/0972